Revvity, Inc. trades near 52-week highs, buoyed by sector M&A momentum but faces fundamental headwinds. RVTY's projected 2026 revenues are flat over 2025, underperforming the Life Sciences sector's 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results